Genetically engineered live-attenuated cytomegalovirus (CMV) vaccines improve pregnancy outcome in the guinea-pig model of congenital CMV infection

Authors

Mark R. Schleiss, Center for Infectious Diseases and Microbiology Translational Research
Alistair McGregor, Center for Infectious Diseases and Microbiology Translational Research
Yeon Choi, Center for Infectious Diseases and Microbiology Translational Research
Jodi Anderson, Center for Infectious Diseases and Microbiology Translational Research
Mike Levinton, Center for Infectious Diseases and Microbiology Translational Research
Xiaohong Cui, Virginia Commonwealth UniversityFollow
Michael McVoy, Virginia Commonwealth UniversityFollow

Document Type

Article

Original Publication Date

2008

Journal/Book/Conference Title

Fourth Dominique International Conference. Maternal chronic viral infections transmitted to infants: from mechanisms to prevention and care

Volume

5

Issue

1

DOI of Original Publication

10.1186/1742-4690-5-S1-P4

Comments

Originally found at http://dx.doi.org/10.1186/1742-4690-5-S1-P4

Date of Submission

August 2014

Rights

© 2008 Schleiss et al.; licensee BioMed Central Ltd.

Is Part Of

VCU Pediatrics Publications